DYANA THOMPSON: Open Payments
NPI 1700485711 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,982 in 117 payments from 15 companies in 2025. Trend: 2023 $697 · 2024 $1,228 · 2025 $1,982
Food & beverage: $1,982
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $515 |
| Alkermes, Inc. | 17 | $324 |
| Neurocrine BioSciences, Inc. | 11 | $186 |
| Janssen Pharmaceuticals, Inc | 11 | $185 |
| Vanda Pharmaceuticals Inc. | 10 | $169 |
| Otsuka America Pharmaceutical, Inc. | 7 | $133 |
| Teva Pharmaceuticals USA, Inc. | 6 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $92 |
| Luye Pharma (USA) Ltd. | 3 | $60 |
| Lundbeck LLC | 3 | $55 |
Products named: VRAYLAR, ARISTADA, INGREZZA, INVEGA SUSTENNA, REXULTI, FANAPT, CAPLYTA, HETLIOZ.
Industry payments across NJ — which companies pay providers there.
